Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Yandex and Russian Post completed a pilot on parcel delivery by robots

11/16/23 YNDX

Alibaba Group announced a quarterly dividend

11/16/23 BABA

Alibaba reported for 6 months of fiscal 2024

11/16/23 BABA

Ozon is preparing to redomicile to Russia

11/16/23 OZON

PulteGroup announced a quarterly dividend

11/16/23 PHM

Samolet first to launch digital mortgages

11/16/23 SMLT

NetEase announced a quarterly dividend

11/16/23 NTES

NetEase reported for 9 months of 2023

11/16/23 NTES

RosDorBank reported for 9 months of 2023 by RAS

11/16/23 RDRB

Kamaz unmanned have traveled 560,000 kilometers

11/16/23 KMAZ